<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26998" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Perioral Dermatitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tolaymat</surname>
            <given-names>Leila</given-names>
          </name>
          <aff>Mayo Clinic Jacksonville</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hall</surname>
            <given-names>Matthew R.</given-names>
          </name>
          <aff>Mayo Clinic</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Leila Tolaymat declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Matthew Hall declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>4</day>
          <month>9</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26998.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Perioral dermatitis is a benign eruption that occurs most commonly in young, female adults, consisting of small inflammatory papules and pustules or pink, scaly patches around the mouth. Although the perioral region is the most common area of distribution, this disease also can affect the periocular and paranasal skin. For this reason, it is often referred to as periorificial dermatitis. This activity reviews the etiology and presentation of perioral dermatitis and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of perioral dermatitis.</p></list-item><list-item><p>Review the presentation of perioral dermatitis.</p></list-item><list-item><p>Outline the treatment and management options available for perioral dermatitis.</p></list-item><list-item><p>Describe interprofessional team strategies for improving care and outcomes in patients with perioral dermatitis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26998&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26998">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26998.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Perioral dermatitis is a benign eruption that occurs&#x000a0;most commonly in&#x000a0;young, female adults, consisting of small inflammatory papules and pustules or&#x000a0;pink, scaly&#x000a0;patches around the mouth. Although the perioral region is the most common area of distribution, this disease also can affect the periocular and paranasal skin. For this reason, it is often referred to as periorificial dermatitis. Topical steroid use to the face can trigger this, and therefore, a primary recommendation for treatment would be discontinuation of&#x000a0;steroid&#x000a0;application by the patient. Other treatment approaches include topical metronidazole, topical calcineurin inhibitors, and oral tetracycline antibiotics. Perioral dermatitis often responds readily to therapy but can be chronic and recurrent.</p>
      </sec>
      <sec id="article-26998.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The exact cause of perioral dermatitis is unknown.&#x000a0;It has multiple environmental exposures linked to its etiology. For some patients, there is an association between topical corticosteroid use and perioral dermatitis.<xref ref-type="bibr" rid="article-26998.r1">[1]</xref>&#x000a0;Topical&#x000a0;steroid use may precede the eruption, and chronic use of topical steroids increases the risk of developing severe disease.<xref ref-type="bibr" rid="article-26998.r2">[2]</xref>&#x000a0;Initially, the facial eruption is responsive to the use of the topical steroid. However, upon withdrawal of the topical steroid, the eruption recurs. This leads to long-term dependency on topical steroid use.<xref ref-type="bibr" rid="article-26998.r3">[3]</xref>&#x000a0;Eventually, perioral dermatitis&#x000a0;may progress&#x000a0;in severity with chronic steroid use and may evolve into a granulomatous subtype of the disease. In addition to topical steroid use, perioral dermatitis has been reported to occur with the use of nasal and inhaled corticosteroids.<xref ref-type="bibr" rid="article-26998.r4">[4]</xref><xref ref-type="bibr" rid="article-26998.r5">[5]</xref>&#x000a0;The exact mechanism&#x000a0;through which&#x000a0;topical steroids predispose patients to perioral dermatitis is not understood. It has been postulated that topical steroids influence the microflora of the hair follicle, which may contribute to the pathogenesis of this condition.<xref ref-type="bibr" rid="article-26998.r6">[6]</xref><xref ref-type="bibr" rid="article-26998.r7">[7]</xref><xref ref-type="bibr" rid="article-26998.r8">[8]</xref>&#x000a0;Some investigators have proposed infectious sources as a cause for perioral dermatitis, including <italic toggle="yes">Candida albicans</italic>, fusiform bacteria,&#x000a0;and <italic toggle="yes">Demodex</italic> mites.<xref ref-type="bibr" rid="article-26998.r6">[6]</xref><xref ref-type="bibr" rid="article-26998.r7">[7]</xref><xref ref-type="bibr" rid="article-26998.r8">[8]</xref>&#x000a0;Fluorinated toothpaste use has also been&#x000a0;associated with perioral dermatitis.<xref ref-type="bibr" rid="article-26998.r9">[9]</xref>&#x000a0;Additionally, chewing gum and dental fillings have been associated with perioral dermatitis.<xref ref-type="bibr" rid="article-26998.r10">[10]</xref><xref ref-type="bibr" rid="article-26998.r11">[11]</xref>&#x000a0;Certain cosmetic products, such as&#x000a0;combined use of moisturizers and foundations, as well as physical sunscreens, have been etiologic in some patients.<xref ref-type="bibr" rid="article-26998.r12">[12]</xref><xref ref-type="bibr" rid="article-26998.r13">[13]</xref>&#x000a0;Given the female predominance with this condition, hormonal factors have been considered in the etiology. Interestingly, oral contraceptive pills have been associated with the improvement of perioral dermatitis.<xref ref-type="bibr" rid="article-26998.r14">[14]</xref></p>
      </sec>
      <sec id="article-26998.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Perioral dermatitis&#x000a0;commonly affects young adult females, 20 to 45 years of age.<xref ref-type="bibr" rid="article-26998.r15">[15]</xref><xref ref-type="bibr" rid="article-26998.r16">[16]</xref>&#x000a0;However, it also has been reported in children.<xref ref-type="bibr" rid="article-26998.r17">[17]</xref>&#x000a0;There is no&#x000a0;significant&#x000a0;difference in&#x000a0;frequency of perioral dermatitis among gender or race in pediatric populations.<xref ref-type="bibr" rid="article-26998.r18">[18]</xref></p>
      </sec>
      <sec id="article-26998.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The clinical manifestations of perioral dermatitis occur when perifollicular and perivascular inflammation lead to erythematous papules around the mouth, eyes, and nose.&#x000a0;The exact mechanism is unknown. The cause is likely multifactorial with contributions from genetic, hormonal, and environmental factors.<xref ref-type="bibr" rid="article-26998.r19">[19]</xref></p>
      </sec>
      <sec id="article-26998.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>A skin biopsy of perioral dermatitis reveals a perifollicular and perivascular lymphohistiocytic inflammatory infiltrate with sparse plasma cells. Although there&#x000a0;may be follicular spongiosis, typical features of dermatitis are often not present despite this term being used to name the disease.<xref ref-type="bibr" rid="article-26998.r20">[20]</xref>&#x000a0;There is a granulomatous variant of perioral dermatitis in which there are dermal epithelioid granulomas and giant cells, in addition to the perivascular and perifollicular lymphohistiocytic inflammation.<xref ref-type="bibr" rid="article-26998.r21">[21]</xref><xref ref-type="bibr" rid="article-26998.r22">[22]</xref></p>
      </sec>
      <sec id="article-26998.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with perioral dermatitis most commonly present with erythematous-grouped papules that are often bilateral but may be unilateral, surrounding the mouth, eyes, and nose.&#x000a0;Since it often affects the skin surrounding other facial orifices, it also has been termed periorificial dermatitis. Other variable findings include scaling, vesicles, and pustules.&#x000a0;The vermillion borders of the lips are typically spared of involvement.&#x000a0;In the granulomatous variant, flesh-colored to erythematous to yellow-brown papules erupt in the same distribution, although rare involvement of the ears, neck, scalp, trunk, vulva, and extremities has been described.<xref ref-type="bibr" rid="article-26998.r23">[23]</xref><xref ref-type="bibr" rid="article-26998.r24">[24]</xref>&#x000a0;Patients often report that the areas of involvement are associated with symptoms of burning or sensitivity although pruritus can also occur.<xref ref-type="bibr" rid="article-26998.r25">[25]</xref>&#x000a0;Patients also may mention sensitivity to various skincare products which may exacerbate the rash.<xref ref-type="bibr" rid="article-26998.r26">[26]</xref>&#x000a0;Rare cases of granulomatous periorificial dermatitis may have concomitant blepharitis or conjunctivitis; therefore, an ophthalmologic evaluation should be considered. Other systemic manifestations are not associated with this disease.<xref ref-type="bibr" rid="article-26998.r24">[24]</xref>&#x000a0;Lupoid perioral dermatitis is&#x000a0;a more severe variant form of perioral dermatitis that presents with dense&#x000a0;groupings of red-brown papules. These lesions demonstrate a lupoid infiltrate on diascopy.<xref ref-type="bibr" rid="article-26998.r27">[27]</xref></p>
      </sec>
      <sec id="article-26998.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The vast majority of patients with perioral dermatitis are diagnosed clinically, although skin biopsy should be considered with an atypical presentation or lack of response to treatment. If a bacterial component is suspected, a culture may be obtained. Additionally, a scraping and potassium hydroxide (KOH) prep can be done if&#x000a0;<italic toggle="yes">Candida</italic> is considered to be contributing to the lesions. With a more severe disease presentation,&#x000a0;diascopy can be performed by an experienced clinician.</p>
      </sec>
      <sec id="article-26998.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>First-line treatment options for perioral dermatitis include metronidazole cream or gel, clindamycin lotion or gel, erythromycin gel, topical sulfur preparations, and azelaic acid gel.<xref ref-type="bibr" rid="article-26998.r28">[28]</xref><xref ref-type="bibr" rid="article-26998.r29">[29]</xref><xref ref-type="bibr" rid="article-26998.r30">[30]</xref>&#x000a0;In the treatment of this condition, antibiotics are helpful for their anti-inflammatory properties.&#x000a0;Topical calcineurin inhibitors such as tacrolimus ointment or pimecrolimus cream can also be effective.<xref ref-type="bibr" rid="article-26998.r31">[31]</xref><xref ref-type="bibr" rid="article-26998.r32">[32]</xref><xref ref-type="bibr" rid="article-26998.r33">[33]</xref><xref ref-type="bibr" rid="article-26998.r34">[34]</xref>&#x000a0;Topical sulfur or sulfacetamide preparations, and topical adapalene have been demonstrated to show improvement.<xref ref-type="bibr" rid="article-26998.r35">[35]</xref><xref ref-type="bibr" rid="article-26998.r36">[36]</xref>&#x000a0;Photodynamic therapy using 5-aminolevulinic acid as a photosensitizer has been reported to provide benefit.<xref ref-type="bibr" rid="article-26998.r37">[37]</xref></p>
        <p>If topical therapies are not helpful, or for extensive involvement of perioral dermatitis, oral antibiotics are often helpful.&#x000a0;Tetracycline 250 to 500 mg twice a day, doxycycline 100 mg&#x000a0;twice a day or once a day, and minocycline 100 mg twice a day or once a day, for an 8-12 week tapering course can be prescribed. When tetracycline antibiotics are contraindicated, as they are in children under age 8, nursing mothers, and pregnant females, erythromycin 250 mg to 500 mg daily can be substituted.<xref ref-type="bibr" rid="article-26998.r38">[38]</xref><xref ref-type="bibr" rid="article-26998.r39">[39]</xref>&#x000a0;The goal of oral antibiotic therapy is to provide rapid improvement, but topical therapies should be used concurrently.&#x000a0;Topical therapies may not show peak efficacy until 3 months of daily treatment, so the objective is to stop oral antibiotics if possible after 3 months. However, a subset of patients may require longer courses of oral antibiotics if they cannot be controlled with chronic daily topical therapies.&#x000a0;In recalcitrant and severe cases, low-dose oral isotretinoin can be used, initially at 0.2 mg/kg per day, then tapering to 0.1 to 0.05 mg/kg per day.<xref ref-type="bibr" rid="article-26998.r40">[40]</xref><xref ref-type="bibr" rid="article-26998.r41">[41]</xref></p>
        <p>It is important to recognize that since perioral dermatitis is not a primary eczematous process, topical corticosteroids should not be used.&#x000a0;Although topical corticosteroids may provide a temporary benefit, when they are discontinued, the rash can often flare and worsen.&#x000a0;If patients have been using topical corticosteroids to treat the eruption, abrupt discontinuation may lead to rebound flaring, and patients should be forewarned that the condition will likely worsen until it improves with the initiation of appropriate&#x000a0;therapies for perioral dermatitis.&#x000a0;If a patient has been using a medium to high potency steroid, it may need to be slowly weaned by using a low potency steroid such as hydrocortisone cream.</p>
      </sec>
      <sec id="article-26998.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Rosacea presents as inflammatory papules and pustules, primarily of the central face, including the nose. Patients often have accompanying telangiectatic erythema with flushing. Many authors view perioral dermatitis as a variant of rosacea, as the 2 conditions typically respond to the same therapies.&#x000a0;Clinically, this is distinguished from acne vulgaris by the lack of comedones which are&#x000a0;characteristic of acne.</p>
          </list-item>
          <list-item>
            <p>Acne vulgaris presents as inflammatory papules, pustules, cysts, and comedones primarily on the face,&#x000a0;but may also affect the chest and back. Patients may have flares of acne secondary to mechanical mechanisms, such as from a&#x000a0;helmet chin strap. The distribution of involvement may mimic perioral dermatitis. Adult female acne is characterized by inflammatory papules of the chin and jawline and can have a similar distribution as perioral dermatitis.</p>
          </list-item>
          <list-item>
            <p>Sarcoidosis can also manifest features similar to rosacea and perioral dermatitis with red-brown papules on periorificial regions of the face.&#x000a0;Typically, lesions of sarcoidosis are more widespread and can occur on other locations of the skin, and patients often have symptoms of systemic sarcoidosis.&#x000a0;A biopsy is helpful in distinguishing sarcoidosis.</p>
          </list-item>
          <list-item>
            <p>Seborrheic dermatitis presents as ill-defined erythematous patches with greasy scale distributed on the eyebrows, glabella, paranasal skin, nasolabial folds, beard, scalp, and chest.</p>
          </list-item>
          <list-item>
            <p>Allergic contact dermatitis can also be considered but tends to present with ill-defined scaling macules, patches, and plaques with possible&#x000a0;lichenification.&#x000a0;If patients with perioral dermatitis do not improve with conventional treatments, patch testing should be considered to rule out allergic contact dermatitis from skincare or oral care products.</p>
          </list-item>
          <list-item>
            <p>Irritant cheilitis, such as lip licker's cheilitis, presents with&#x000a0;erythema and scaling of the cutaneous lip. This typically also affects the vermillion lip and does not spare the vermillion border. In contrast, the vermillion border is spared in perioral dermatitis.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Demodex</italic> folliculitis presents with scattered erythematous facial papules and pustules.&#x000a0;<italic toggle="yes">Demodex&#x000a0;</italic>mites have been implicated in the pathogenesis of rosacea.&#x000a0;Unroofing of the pustules&#x000a0;followed by&#x000a0;microscopy of the purulent material shows numerous&#x000a0;<italic toggle="yes">Demodex</italic>.</p>
          </list-item>
          <list-item>
            <p>Tinea faciei presents with erythematous scaling papules and annular plaques and can be ruled out by performing a KOH prep and microscopic examination of the scale.</p>
          </list-item>
          <list-item>
            <p>Syringomas and other cutaneous adnexal neoplasms also can mimic perioral dermatitis as these lesions are flesh-colored to erythematous facial papules.&#x000a0;A biopsy is helpful for diagnosis.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26998.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>In some patients, the rash may resolve completely after discontinuation of an offending agent including topical steroids and skincare products. Frequently, however, perioral dermatitis can be a chronic relapsing condition and often requires long-term treatment.</p>
      </sec>
      <sec id="article-26998.s12" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Emotional&#x000a0;distress&#x000a0;due to the chronicity of the disease</p>
          </list-item>
          <list-item>
            <p>Poor quality of life due to sometimes disfiguring lesions on the face</p>
          </list-item>
          <list-item>
            <p>Scarring may&#x000a0;occur with the lupoid variant<xref ref-type="bibr" rid="article-26998.r27">[27]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26998.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>Ophthalmology consultation may be warranted if symptoms of conjunctivitis,&#x000a0;such as burning, itching, or tearing,&#x000a0;are present.</p>
      </sec>
      <sec id="article-26998.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>As previously stated, patients with perioral dermatitis should be made aware of the role of topical steroids in their disease process. In addition to the discontinuation of topical steroids or other triggering agents, patients should also be instructed to stop using all topical products except for their prescribed medication regimen. It is also important to impress upon the patient the time frame for treatment to remission, which could be weeks to months. The likelihood of chronic symptoms should also be discussed in detail.</p>
      </sec>
      <sec id="article-26998.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The majority of patients with perioral dermatitis can be managed effectively and safely by a primary clinician or a dermatologist. However, due to potential toxicity from treatments, it is important for there to be open lines of interprofessional communication between clinicians, nurses, medical assistants, and pharmacists. Patients should be encouraged to contact the office with intolerance of any topical or oral medications. As was discussed, patients may flare with discontinuation of topical steroids, possibly requiring a tapering regimen and frequent follow-up to formulate a treatment plan. Tetracycline antibiotics which are commonly used for treatment also can cause allergic reactions, gastrointestinal upset, and photosensitivity, and therefore, patients should be advised to notify the office with any concerns. [Level 5]</p>
      </sec>
      <sec id="article-26998.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26998&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26998">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/perioral-dermatitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26998">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26998/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26998">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-26998.s17">
        <fig id="article-26998.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Perioral Dermatitis <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="perioral__dermatitis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-26998.s18">
        <title>References</title>
        <ref id="article-26998.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kosari</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Case report: Fluocinonide-induced perioral dermatitis in a patient with psoriasis.</article-title>
            <source>Dermatol Online J</source>
            <year>2009</year>
            <month>Mar</month>
            <day>15</day>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>15</fpage>
            <pub-id pub-id-type="pmid">19379659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ljubojeviae</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Basta-Juzbasiae</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lipozen&#x000e8;iae</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Steroid dermatitis resembling rosacea: aetiopathogenesis and treatment.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2002</year>
            <month>Mar</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>121</fpage>
            <page-range>121-6</page-range>
            <pub-id pub-id-type="pmid">12046812</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hengge</surname>
                <given-names>UR</given-names>
              </name>
              <name>
                <surname>Ruzicka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Cork</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Adverse effects of topical glucocorticosteroids.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-15; quiz 16-8</page-range>
            <pub-id pub-id-type="pmid">16384751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peralta</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Morais</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Perioral dermatitis -- the role of nasal steroids.</article-title>
            <source>Cutan Ocul Toxicol</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>160</fpage>
            <page-range>160-3</page-range>
            <pub-id pub-id-type="pmid">21995785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poulos</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Brodell</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Perioral dermatitis associated with an inhaled corticosteroid.</article-title>
            <source>Arch Dermatol</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>143</volume>
            <issue>11</issue>
            <fpage>1460</fpage>
            <pub-id pub-id-type="pmid">18025385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bradford</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Montes</surname>
                <given-names>LF</given-names>
              </name>
            </person-group>
            <article-title>Perioral dermatitis and Candida albicans.</article-title>
            <source>Arch Dermatol</source>
            <year>1972</year>
            <month>Jun</month>
            <volume>105</volume>
            <issue>6</issue>
            <fpage>892</fpage>
            <page-range>892-5</page-range>
            <pub-id pub-id-type="pmid">4555327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takiwaki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tsuda</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Arase</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Takeichi</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Differences between intrafollicular microorganism profiles in perioral and seborrhoeic dermatitis.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>531</fpage>
            <page-range>531-4</page-range>
            <pub-id pub-id-type="pmid">12950346</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dolenc-Voljc</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pohar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lunder</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Density of Demodex folliculorum in perioral dermatitis.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2005</year>
            <volume>85</volume>
            <issue>3</issue>
            <fpage>211</fpage>
            <page-range>211-5</page-range>
            <pub-id pub-id-type="pmid">16040404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peters</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Drummond</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Perioral dermatitis from high fluoride dentifrice: a case report and review of literature.</article-title>
            <source>Aust Dent J</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>58</volume>
            <issue>3</issue>
            <fpage>371</fpage>
            <page-range>371-2</page-range>
            <pub-id pub-id-type="pmid">23981221</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Satyawan</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Oranje</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>van Joost</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Perioral dermatitis in a child due to rosin in chewing gum.</article-title>
            <source>Contact Dermatitis</source>
            <year>1990</year>
            <month>Mar</month>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>182</fpage>
            <page-range>182-3</page-range>
            <pub-id pub-id-type="pmid">2335094</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guarneri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Marini</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Perioral dermatitis after dental filling in a 12-year-old girl: involvement of cholinergic system in skin neuroinflammation?</article-title>
            <source>ScientificWorldJournal</source>
            <year>2008</year>
            <month>Feb</month>
            <day>06</day>
            <volume>8</volume>
            <fpage>157</fpage>
            <page-range>157-63</page-range>
            <pub-id pub-id-type="pmid">18264633</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malik</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Quirk</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Topical applications and perioral dermatitis.</article-title>
            <source>Australas J Dermatol</source>
            <year>2000</year>
            <month>Feb</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <page-range>34-8</page-range>
            <pub-id pub-id-type="pmid">10715898</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abeck</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Geisenfelder</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Brandt</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Physical sunscreens with high sun protection factor may cause perioral dermatitis in children.</article-title>
            <source>J Dtsch Dermatol Ges</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>7</volume>
            <issue>8</issue>
            <fpage>701</fpage>
            <page-range>701-3</page-range>
            <pub-id pub-id-type="pmid">19250246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spirov</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Berova</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Vassilev</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Effect of oral inhibitors of ovulation in treatment of rosacea and dermatitis perioralis in women.</article-title>
            <source>Australas J Dermatol</source>
            <year>1971</year>
            <month>Dec</month>
            <volume>12</volume>
            <fpage>145</fpage>
            <page-range>145-54</page-range>
            <pub-id pub-id-type="pmid">12305771</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hogan</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Epstein</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>Perioral dermatitis: an uncommon condition?</article-title>
            <source>CMAJ</source>
            <year>1986</year>
            <month>May</month>
            <day>01</day>
            <volume>134</volume>
            <issue>9</issue>
            <fpage>1025</fpage>
            <page-range>1025-8</page-range>
            <pub-id pub-id-type="pmid">2938708</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lipozencic</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ljubojevic</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Perioral dermatitis.</article-title>
            <source>Clin Dermatol</source>
            <year>2011</year>
            <season>Mar-Apr</season>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>157</fpage>
            <page-range>157-61</page-range>
            <pub-id pub-id-type="pmid">21396555</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manders</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Lucky</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Perioral dermatitis in childhood.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1992</year>
            <month>Nov</month>
            <volume>27</volume>
            <issue>5 Pt 1</issue>
            <fpage>688</fpage>
            <page-range>688-92</page-range>
            <pub-id pub-id-type="pmid">1430388</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laude</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Salvemini</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Perioral dermatitis in children.</article-title>
            <source>Semin Cutan Med Surg</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>206</fpage>
            <page-range>206-9</page-range>
            <pub-id pub-id-type="pmid">10468040</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tempark</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shwayder</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Perioral dermatitis: a review of the condition with special attention to treatment options.</article-title>
            <source>Am J Clin Dermatol</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>101</fpage>
            <page-range>101-13</page-range>
            <pub-id pub-id-type="pmid">24623018</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marks</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Perioral dermatitis. A histopathologic study of 26 cases.</article-title>
            <source>Br J Dermatol</source>
            <year>1971</year>
            <month>Mar</month>
            <volume>84</volume>
            <issue>3</issue>
            <fpage>242</fpage>
            <page-range>242-7</page-range>
            <pub-id pub-id-type="pmid">5572676</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frieden</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>Prose</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Granulomatous perioral dermatitis in children.</article-title>
            <source>Arch Dermatol</source>
            <year>1989</year>
            <month>Mar</month>
            <volume>125</volume>
            <issue>3</issue>
            <fpage>369</fpage>
            <page-range>369-73</page-range>
            <pub-id pub-id-type="pmid">2923443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramelet</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Delacr&#x000e9;taz</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[Histopathologic study of perioral dermatitis].</article-title>
            <source>Dermatologica</source>
            <year>1981</year>
            <volume>163</volume>
            <issue>5</issue>
            <fpage>361</fpage>
            <page-range>361-9</page-range>
            <pub-id pub-id-type="pmid">7333393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nguyen</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Eichenfield</surname>
                <given-names>LF</given-names>
              </name>
            </person-group>
            <article-title>Periorificial dermatitis in children and adolescents.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>55</volume>
            <issue>5</issue>
            <fpage>781</fpage>
            <page-range>781-5</page-range>
            <pub-id pub-id-type="pmid">17052482</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Urbatsch</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Frieden</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Elewski</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Mancini</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Paller</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Extrafacial and generalized granulomatous periorificial dermatitis.</article-title>
            <source>Arch Dermatol</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>138</volume>
            <issue>10</issue>
            <fpage>1354</fpage>
            <page-range>1354-8</page-range>
            <pub-id pub-id-type="pmid">12374542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuflik</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Janniger</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Piela</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Perioral dermatitis: an acneiform eruption.</article-title>
            <source>Cutis</source>
            <year>2001</year>
            <month>Jan</month>
            <volume>67</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-2</page-range>
            <pub-id pub-id-type="pmid">11204598</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilkinson</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Kirton</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Perioral dermatitis: a 12-year review.</article-title>
            <source>Br J Dermatol</source>
            <year>1979</year>
            <month>Sep</month>
            <volume>101</volume>
            <issue>3</issue>
            <fpage>245</fpage>
            <page-range>245-57</page-range>
            <pub-id pub-id-type="pmid">159711</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baratli</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Megahed</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Lupoid perioral dermatitis as a special form of perioral dermatitis: review of pathogenesis and new therapeutic options].</article-title>
            <source>Hautarzt</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>64</volume>
            <issue>12</issue>
            <fpage>888</fpage>
            <page-range>888-90</page-range>
            <pub-id pub-id-type="pmid">24201654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Veien</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Munkvad</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Niordson</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Stahl</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Thormann</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Topical metronidazole in the treatment of perioral dermatitis.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1991</year>
            <month>Feb</month>
            <volume>24</volume>
            <issue>2 Pt 1</issue>
            <fpage>258</fpage>
            <page-range>258-60</page-range>
            <pub-id pub-id-type="pmid">2007672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Shalita</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Topical metronidazole gel (0.75%) for the treatment of perioral dermatitis in children.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1994</year>
            <month>Nov</month>
            <volume>31</volume>
            <issue>5 Pt 2</issue>
            <fpage>847</fpage>
            <page-range>847-8</page-range>
            <pub-id pub-id-type="pmid">7962733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jansen</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Azelaic acid as a new treatment for perioral dermatitis: results from an open study.</article-title>
            <source>Br J Dermatol</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>151</volume>
            <issue>4</issue>
            <fpage>933</fpage>
            <page-range>933-4</page-range>
            <pub-id pub-id-type="pmid">15491447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldman</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2001</year>
            <month>Jun</month>
            <volume>44</volume>
            <issue>6</issue>
            <fpage>995</fpage>
            <page-range>995-8</page-range>
            <pub-id pub-id-type="pmid">11369912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chu</surname>
                <given-names>CY</given-names>
              </name>
            </person-group>
            <article-title>The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea.</article-title>
            <source>Br J Dermatol</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>152</volume>
            <issue>2</issue>
            <fpage>396</fpage>
            <page-range>396-9</page-range>
            <pub-id pub-id-type="pmid">15727676</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gerber</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Neumann</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Ruzicka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bruch-Gerharz</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>[Perioral dermatitis following treatment with tacrolimus].</article-title>
            <source>Hautarzt</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>56</volume>
            <issue>10</issue>
            <fpage>967</fpage>
            <page-range>967-8</page-range>
            <pub-id pub-id-type="pmid">16142496</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwarz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kreiselmaier</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bieber</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Thaci</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Meurer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Werfel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zuberbier</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Luger</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Wollenberg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Br&#x000e4;utigam</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <page-range>34-40</page-range>
            <pub-id pub-id-type="pmid">18462835</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bendl</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Perioral dermatitis: etiology and treatment.</article-title>
            <source>Cutis</source>
            <year>1976</year>
            <month>May</month>
            <volume>17</volume>
            <issue>5</issue>
            <fpage>903</fpage>
            <page-range>903-8</page-range>
            <pub-id pub-id-type="pmid">1035149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jansen</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Perioral dermatitis successfully treated with topical adapalene.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2002</year>
            <month>Mar</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>175</fpage>
            <page-range>175-7</page-range>
            <pub-id pub-id-type="pmid">12046830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Richey</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Hopson</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Photodynamic therapy for perioral dermatitis.</article-title>
            <source>J Drugs Dermatol</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>5</volume>
            <issue>2 Suppl</issue>
            <fpage>12</fpage>
            <page-range>12-6</page-range>
            <pub-id pub-id-type="pmid">16485876</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choi</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>DY</given-names>
              </name>
            </person-group>
            <article-title>Case of childhood granulomatous periorificial dermatitis in a Korean boy treated by oral erythromycin.</article-title>
            <source>J Dermatol</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>33</volume>
            <issue>11</issue>
            <fpage>806</fpage>
            <page-range>806-8</page-range>
            <pub-id pub-id-type="pmid">17073999</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ellis</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Stawiski</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>The treatment of perioral dermatitis, acne rosacea, and seborrheic dermatitis.</article-title>
            <source>Med Clin North Am</source>
            <year>1982</year>
            <month>Jul</month>
            <volume>66</volume>
            <issue>4</issue>
            <fpage>819</fpage>
            <page-range>819-30</page-range>
            <pub-id pub-id-type="pmid">6212726</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>KW</given-names>
              </name>
            </person-group>
            <article-title>Perioral dermatitis with histopathologic features of granulomatous rosacea: successful treatment with isotretinoin.</article-title>
            <source>Cutis</source>
            <year>1990</year>
            <month>Nov</month>
            <volume>46</volume>
            <issue>5</issue>
            <fpage>413</fpage>
            <page-range>413-5</page-range>
            <pub-id pub-id-type="pmid">2148143</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26998.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lipozen&#x0010d;i&#x00107;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Had&#x0017e;avdi&#x00107;</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Perioral dermatitis.</article-title>
            <source>Clin Dermatol</source>
            <year>2014</year>
            <season>Jan-Feb</season>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>125</fpage>
            <page-range>125-30</page-range>
            <pub-id pub-id-type="pmid">24314386</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
